SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________
FORM 8-K
_____________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
_____________
Date of report (Date of earliest event reported): | December 16, 2003 |
TUTOGEN MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Florida | 01-16128 | 59-3100165 | ||
(State or other jurisdiction of | (Commission file number) | (I.R.S. Employer | ||
incorporation or organization) | Identification No.) |
1130 McBride Avenue
3rd Floor
West Patterson, New Jersey 07424
(Address of principal executive offices) (Zip Code)
(973) 785-0004
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Item 12. Results of Operations and Financial Condition
On December 16, 2003, Tutogen Medical, Inc. issued a press release announcing its financial results for the fiscal year ended September 30, 2003. A copy of the press release is furnished as Exhibit 99.1 to this current report.
The information in this report shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TUTOGEN MEDICAL, INC. | ||||
(Registrant) | ||||
By: | /s/ George Lombardi | |||
George Lombardi | ||||
Chief Financial Officer | ||||
Date: December 19, 2003 |
3
INDEX TO EXHIBITS
Exhibit | ||
Number | Description | |
99.1 | Text of Press release issued by Tutogen Medical, Inc., dated December 16, 2003 |
4